Are Dose-Dense and Triplet Chemotherapy Regimens Optimal Adjuvant Therapy in the Majority of Women With Node-Positive Early Breast Cancer?

被引：3
|
作者：
Moylan, Eugene J. [1 ]
Connell, Louise C. [2 ]
O'Reilly, Seamus [2 ]
机构：
[1] Liverpool Hosp, Liverpool, Merseyside, Australia
[2] Cork Univ Hosp, Cork, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 06期
关键词：
D O I：
10.1200/JCO.2013.53.6771
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：605 / 606
页数：2
相关论文
共 50 条
  • [1] Dose-dense chemotherapy for node-positive breast cancer
    Citron, ML
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (03) : 227 - 227
  • [2] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [3] Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
    S Kümmel
    J Krocker
    A Kohls
    G-P Breitbach
    G Morack
    M Budner
    J-U Blohmer
    D Elling
    [J]. British Journal of Cancer, 2006, 94 : 1237 - 1244
  • [4] Randomised trial:: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
    Kümmel, S
    Krocker, J
    Kohls, A
    Breitbach, GP
    Morack, G
    Budner, M
    Blohmer, JU
    Elling, D
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1237 - 1244
  • [5] Dose-dense anthracycline-based chemotherapy for node-positive breast cancer
    Ellis, GK
    Livingston, RB
    Gralow, JR
    Green, SJ
    Thompson, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3637 - 3643
  • [6] Safety and tolerability of adjuvant dose dense chemotherapy in elderly patients with node-positive early breast cancer
    Karavasilis, Vasilios
    Pectasides, Dimitrios G.
    Papadimitriou, Christos A.
    Gogas, Helen
    Kouvatseas, George
    Christodoulou, Christos
    Koutras, Angelos
    Pentheroudakis, George E.
    Linardou, Helena
    Razis, Evangella
    Aravantinos, Gerasimos
    Dimopoulos, Meletios A.
    Fountzilas, George
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer patients in a randomised trial.
    Kummel, S.
    Krocker, J.
    Kohls, A.
    Breitbach, G-P
    Budner, M.
    Keil, E.
    Hinke, A.
    Blohmer, J-U
    Elling, D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S113 - S113
  • [8] Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older:: Feasibility and tolerability in a subset of patients in a randomized trial
    Kümmel, S
    Krocker, J
    Kohs, A
    Breitbach, GP
    Morack, G
    Budner, M
    Blohmer, JU
    Lichtenegger, W
    Elling, D
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 58 (02) : 166 - 175
  • [9] Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis
    Khoshroo, Sara
    Sandoughdaran, Saleh
    Sabetrasekh, Parisa
    Hajian, Parastoo
    Bikdeli, Pegah
    Sabetrasekh, Parto
    Nasrollahi, Fatemeh
    Yeganeh, Ladan Mohammadi
    Naeini, Sepideh Jafari
    Mirzaei, Hamid Reza
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2021, 2021
  • [10] Dose-dense adjuvant chemotherapy for breast cancer
    Ziegler, JoAnne
    Citron, Marc
    [J]. CANCER NURSING, 2006, 29 (04) : 266 - 272
12345